DTDavid Provenzale Titinger

David Provenzale Titinger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Provenzale Titinger has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diretriz Brasileira de Valvopatias – 2026

    by Flavio Tarasoutchi, João Ricardo Cordeiro Fernandes, Vitor Emer Egypto Rosa, Roney Orismar Sampaio, Diana Patricia Lamprea Sepulveda, Auristela Isabel de Oliveira Ramos, Carlos Augusto Homem de Magalhães Campos, Fernando Ribeiro de Moraes, Alberto Rodolpho Hüning, Alberto Takeshi Kiyose, et al.

    Sumário […] Diretriz Brasileira de Valvopatias – 2026 Sumário […] Diretriz Brasileira de Valvopatias – 2026

  • Open Access

    Frailty in Patients With Valve Disease: How to Assess?

    by David Provenzale Titinger, Vitor Emer Egypto Rosa, Marcelo Eidi Ochiai, Tarso Augusto Accorsi, João Ricardo Cordeiro Fernandes, Roney Orismar Sampaio, Flávio Tarasoutchi

    Introduction Valvular heart disease contributes to an important portion of hospital admissions. It can progress to heart failure and death, and it ranks eighth among the causes of mortality due to cardiovascular diseases in Brazil. From the moment that a valve disease becomes anatomically important and has clinical repercussions, only interventional treatment (conventional surgery or transcatheter technique) is able to alter the natural course of the disease., The choice of intervention leads to the need for individualized evaluation of the [...] Introduction Valvular heart disease contributes to an important portion of hospital admissions. It can progress to heart failure and death, and it ranks eighth among the causes of mortality due to cardiovascular diseases in Brazil. From the moment that a valve disease becomes anatomically important and has clinical repercussions, only interventional treatment (conventional surgery or transcatheter technique) is able to alter the natural course of the disease., The choice of intervention leads to the need for individualized evaluation of the

  • Open Access

    Cardiac Surgery Costs According to the Preoperative Risk in the Brazilian Public Health System

    by David Provenzale Titinger, Luiz Augusto Ferreira Lisboa, Bruna La Regina Matrangolo, Luis Alberto Oliveira Dallan, Evelinda Marramon Trindade, Ivone Eckl, Roberto Kalil Filho, Omar Asdrúbal Vilca Mejía, Fabio Biscegli Jatene

    Heart surgery has developed with increasing patient complexity. To assess the use of resources and real costs stratified by risk factors of patients submitted to surgical cardiac procedures and to compare them with the values reimbursed by the Brazilian Unified Health System (SUS). All cardiac surgery procedures performed between January and July 2013 in a tertiary referral center were analyzed. Demographic and clinical data allowed the calculation of the value reimbursed by the Brazilian SUS. Patients were stratified as low, intermediate and high-risk categories according to the EuroSCORE. Clinical outcomes, use of resources and costs (real costs versus SUS) were compared between established risk groups. Postoperative mortality rates of low, intermediate and high-risk EuroSCORE risk strata showed a significant linear positive correlation (EuroSCORE: 3.8%, 10%, and 25%; p < 0.0001), as well as occurrence of any postoperative complication EuroSCORE: 13.7%, 20.7%, and 30.8%, respectively; p = 0.006). Accordingly, length-of-stay increased from 20.9 days to 24.8 and 29.2 days (p < 0.001). The real cost was parallel to increased resource use according to EuroSCORE risk strata (R$ 27.116,00 ± R$ 13.928,00 versus R$ 34.854,00 ± R$ 27.814,00 versus R$ 43.234,00 ± R$ 26.009,00, respectively; p < 0.001). SUS reimbursement also increased (R$ 14.306,00 ± R$ 4.571,00 versus R$ 16.217,00 ± R$ 7.298,00 versus R$ 19.548,00 ± R$935,00; p < 0.001). However, as the EuroSCORE increased, there was significant difference (p < 0.0001) between the real cost increasing slope and the SUS reimbursement elevation per EuroSCORE risk strata. Higher EuroSCORE was related to higher postoperative mortality, complications, length of stay, and costs. Although SUS reimbursement increased according to risk, it was not proportional to real costs.